BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 20837891)

  • 1. Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry.
    Schwartz PJ; Spazzolini C; Priori SG; Crotti L; Vicentini A; Landolina M; Gasparini M; Wilde AA; Knops RE; Denjoy I; Toivonen L; Mönnig G; Al-Fayyadh M; Jordaens L; Borggrefe M; Holmgren C; Brugada P; De Roy L; Hohnloser SH; Brink PA
    Circulation; 2010 Sep; 122(13):1272-82. PubMed ID: 20837891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable cardioverter-defibrillator therapy in patients with congenital long-QT syndrome: a long-term follow-up.
    Mönnig G; Köbe J; Löher A; Eckardt L; Wedekind H; Scheld HH; Haverkamp W; Milberg P; Breithardt G; Schulze-Bahr E; Böcker D
    Heart Rhythm; 2005 May; 2(5):497-504. PubMed ID: 15840474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long QT syndrome in children in the era of implantable defibrillators.
    Etheridge SP; Sanatani S; Cohen MI; Albaro CA; Saarel EV; Bradley DJ
    J Am Coll Cardiol; 2007 Oct; 50(14):1335-40. PubMed ID: 17903632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter defibrillator therapy for congenital long QT syndrome: a single-center experience.
    Horner JM; Kinoshita M; Webster TL; Haglund CM; Friedman PA; Ackerman MJ
    Heart Rhythm; 2010 Nov; 7(11):1616-22. PubMed ID: 20816872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardioverter defibrillator treatment in long QT syndrome patients: a national study on adherence to international guidelines.
    Sundström E; Jensen SM; Diamant UB; Rydberg A
    Scand Cardiovasc J; 2017 Apr; 51(2):88-94. PubMed ID: 27936942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU).
    Rosso R; Glick A; Glikson M; Wagshal A; Swissa M; Rosenhek S; Shetboun I; Khalamizer V; Fuchs T; Boulos M; Geist M; Strasberg B; Ilan M; Belhassen B;
    Isr Med Assoc J; 2008 Jun; 10(6):435-9. PubMed ID: 18669142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital long QT 3 in the pediatric population.
    Blaufox AD; Tristani-Firouzi M; Seslar S; Sanatani S; Trivedi B; Fischbach P; Paul T; Young ML; Tisma-Dupanovic S; Silva J; Cuneo B; Fournier A; Singh H; Tanel RE; Etheridge SP
    Am J Cardiol; 2012 May; 109(10):1459-65. PubMed ID: 22360817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome.
    Schwartz PJ; Priori SG; Cerrone M; Spazzolini C; Odero A; Napolitano C; Bloise R; De Ferrari GM; Klersy C; Moss AJ; Zareba W; Robinson JL; Hall WJ; Brink PA; Toivonen L; Epstein AE; Li C; Hu D
    Circulation; 2004 Apr; 109(15):1826-33. PubMed ID: 15051644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Italian Implantable Cardioverter-Defibrillator Registry. A survey of the national activity during the years 2001-2003.
    Proclemer A; Ghidina M; Cicuttini G; Gregori D; Fioretti PM
    Ital Heart J; 2005 Mar; 6(3):272-80. PubMed ID: 15875520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of implantable cardioverter defibrillator therapy in patients with acquired long QT syndrome: a long-term follow-up.
    Mönnig G; Köbe J; Löher A; Wasmer K; Milberg P; Zellerhoff S; Pott C; Zumhagen S; Radu R; Scheld HH; Haverkamp W; Schulze-Bahr E; Eckardt L
    Europace; 2012 Mar; 14(3):396-401. PubMed ID: 21979994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical course and risk stratification of patients affected with the Jervell and Lange-Nielsen syndrome.
    Goldenberg I; Moss AJ; Zareba W; McNitt S; Robinson JL; Qi M; Towbin JA; Ackerman MJ; Murphy L
    J Cardiovasc Electrophysiol; 2006 Nov; 17(11):1161-8. PubMed ID: 16911578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter defibrillator therapy for prevention of sudden cardiac death in children in the Netherlands.
    Heersche JH; Blom NA; van de Heuvel F; Blank C; Reimer AG; Clur SA; Witsenburg M; ten Harkel AD
    Pacing Clin Electrophysiol; 2010 Feb; 33(2):179-85. PubMed ID: 20025697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Implantable cardioverter-defibrillators in patients resuscitated from sudden death and in patients with sustained refractory ventricular tachycardia].
    Adragão P; Parreira L; Neves J; Morgado F; Abecassis M; Almeida M; Martins D; Bonhorst D; Seabra-Gomes R
    Rev Port Cardiol; 1996 Mar; 15(3):195-206, 179, 181. PubMed ID: 8634168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial Arrhythmias in long-QT syndrome under daily life conditions: a nested case control study.
    Zellerhoff S; Pistulli R; Mönnig G; Hinterseer M; Beckmann BM; Köbe J; Steinbeck G; Kääb S; Haverkamp W; Fabritz L; Gradaus R; Breithardt G; Schulze-Bahr E; Böcker D; Kirchhof P
    J Cardiovasc Electrophysiol; 2009 Apr; 20(4):401-7. PubMed ID: 19017345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of implantable cardioverter-defibrillators in patients with methadone-induced long QT syndrome.
    Patel AM; Singh JP; Ruskin JN
    Am J Cardiol; 2008 Jan; 101(2):209-11. PubMed ID: 18178408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spanish implantable cardioverter-defibrillator registry. 5th official report of the spanish society of cardiology working group on implantable cardioverter-defibrillators (2008).
    Peinado R; Torrecilla EG; Ormaetxe J; Alvarez M; Cózar R; Alzueta J;
    Rev Esp Cardiol; 2009 Dec; 62(12):1435-49. PubMed ID: 20038409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study.
    Ladwig KH; Baumert J; Marten-Mittag B; Kolb C; Zrenner B; Schmitt C
    Arch Gen Psychiatry; 2008 Nov; 65(11):1324-30. PubMed ID: 18981344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Spanish implantable cardioverter-defibrillator registry. First official report of the spanish society of cardiology working group on implantable cardioverter-defibrillators (2002-2004)].
    Peinado R; Arenal A; Arribas F; Torrecilla E; Alvarez M; Ormaetxe JM; Pérez-Castellano N
    Rev Esp Cardiol; 2005 Dec; 58(12):1435-49. PubMed ID: 16371203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention.
    Olde Nordkamp LR; Wilde AA; Tijssen JG; Knops RE; van Dessel PF; de Groot JR
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):91-100. PubMed ID: 23275262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome.
    Daubert JP; Zareba W; Rosero SZ; Budzikowski A; Robinson JL; Moss AJ
    Am Heart J; 2007 Apr; 153(4 Suppl):53-8. PubMed ID: 17394903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.